Doctors in Britain are zeroing in on a universal cure for the common cold

The common cold might get a bit less common if researchers from the U.K.’s Imperial College London have anything to do with it. They have developed and lab-tested a new molecule that could help battle the cold virus by stopping it from hijacking human cells. Although it’s still in the early stages, their solution has been shown to be effective at completely blocking multiple strains of the cold virus. If this is successfully extrapolated to humans, it could help stop burgeoning sniffles in their tracks.

“Rhinovirus is the most frequent cause of the common cold. In healthy people, this is not usually a serious illness, but if you have asthma, COPD, or cystic fibrosis, this can trigger a significant worsening of your symptoms,” Dr. Roberto Solari at Imperial’s National Heart and Lung Institute, told Digital Trends. “There is currently no vaccine to prevent rhinovirus, and no antiviral drugs to treat it. Like all viruses, RV exploits the machinery of our cells to make new copies of itself and so spread. It has been known since the 1980s that the polio virus, which is a related virus to RV, uses an enzyme from our cells to add a small fat molecule to one its coat proteins. These form the outer shell of the virus. We have made a chemical inhibitor of this enzyme, and found that it blocks the formation of new viruses.”

The challenge with developing a cure to the common cold is that it is caused not by one virus, but by hundreds of variants. While we can develop immunity or resistance to a few of these, it’s almost impossible to do so against all of them. The viruses also rapidly evolve, which allows them to gain resistance to drugs. As a result of these factors, existing cold remedies mainly focus on treating symptoms — such as sore throats and runny noses — rather than the actual virus.

However, the Imperial College research could change that since all strains of the cold virus nonetheless rely on the same protein to make copies of themselves. The molecule could therefore bring an end to the reign of terror of all cold strains — along with other not-insignificant viruses such as polio and foot and mouth disease.

“We are at the preclinical stage,” Solari said. “We have tested it in human cells. The molecule is very potent, but we need to perform additional studies to show its safety and efficacy before it can go into human volunteers.”

A paper describing the research is being published in the journal Nature Chemistry.

Health & Fitness

Immune cell discovery takes us one step closer to a universal flu vaccine

A group of international researchers have made a discovery which could take us one step closer to the universal, one-shot flu vaccine that people around the world have been dreaming of.
Smart Home

Researchers are once again trying to science the gluten out of bread

If you've ever found gluten tough to stomach, help may be on the way. Researchers and farmers are exploring solutions that include gene-edited bread, as well as alterations to carbs and fiber.
Gaming

These are the must-have games that every Xbox One owner needs

More than four years into its life span, Microsoft's latest console is finally coming into its own. From Cuphead to Halo 5, the best Xbox One games offer something for players of every type.
Home Theater

The best movies on Netflix in December, from 'Buster Scruggs’ to 'Roma'

Save yourself from hours wasted scrolling through Netflix's massive library by checking out our picks for the streamer's best movies available right now, whether you're into explosive action, witty humor, or anything else.
Emerging Tech

The Great White Shark’s genome has been decoded, and it could help us end cancer

In a significant step for marine and genetic science, researchers have decoded the genome of the great white shark. The genetic code revealed a wealth of insight into what makes these creatures so successful from an evolutionary standpoint.
Emerging Tech

‘Guerrilla rainstorm’ warning system aims to prevent soakings, or worse

Japanese researchers have created a "guerrilla rainstorm" early-warning system aimed at preventing severe soakings, or worse. The team hopes to launch the system before the 2020 Tokyo Olympics.
Emerging Tech

We tried a $500 electronic dab rig, and now we can’t go back to normal vaporizers

Induction heating is the future of cannabis vaporizers. Loto Labs wowed us with what likely is the best concentrate vaporizer on the market today. With a $500 price tag, it's expensive, but it should definitely be your next dab rig.
Mobile

Barbie’s Corvette ain’t got nothing on Sphero’s fully programmable robot car

Sphero is known for devices like the Sphero Bolt and BB-8 Star Wars toy, but now the company is back with another addition to its lineup -- the Sphero RVR. The RVR is a fully programmable robot car that can be expanding with different…
Emerging Tech

Japanese spacecraft will collect a sample from asteroid Ryugu by shooting at it

The Japanese spacecraft Hayabusa 2 will soon touch down on the asteroid Ryugu, where it will collect a sample by shooting a bullet into the soil. The sample will be returned to Earth in 2020 to learn about the formation of asteroids.
Emerging Tech

Hong Kong’s vision for a smart prison is a full-blown Orwellian nightmare

Hong Kong wants to bring prisons up to date by introducing new location-tracking wristbands for inmates, and a robot arm whose job is to comb through poop on the lookout for contraband.
Emerging Tech

No faking! Doctors can now objectively measure how much pain you’re in

Researchers at Indiana University School of Medicine have discovered the blood biomarkers that can objectively reveal just how much pain a patient is in. Here's why that's so important.
Emerging Tech

SeaBubbles’ new electric hydrofoil boat is the aquatic equivalent of a Tesla

What do you get if you combine a Tesla, a flying car, and a sleek boat? Probably something a bit like SeaBubbles, the French "flying" boat startup which offers a fresh spin on the hydrofoil.
Emerging Tech

Israel will launch world’s first privately funded moon mission tomorrow

This week will see the world's first privately funded lunar mission launch. Israel's first mission to the moon will be launched aboard SpaceX's Falcon 9 rocket on Thursday, February 21.
Emerging Tech

FDA warns about the dangers of anti-aging blood transfusions

It turns out injecting old people with blood from healthy youngsters may not be the answer to health rejuvenation. That’s according to the FDA, which says such claims are dangerous junk science.